Search research articles
Contact Us
Filters
Showing results (161-170 of 195) with videos related to
Page
of 20
Sort By:
Cell Reports
|
September 28, 2022
Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma
Maleeha A Qazi, Sabra K Salim, Kevin R Brown, et al.
Cell
|
July 10, 2004
Exploration of essential gene functions via titratable promoter alleles
Sanie Mnaimneh, Armaity P Davierwala, Jennifer Haynes, et al.
Nature
|
November 25, 2021
FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation
Yuqing Feng, Conglei Li, Jessica A Stewart, et al.
Molecular Cell
|
March 8, 2016
System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes
Wei Zhang, Kuen-Phon Wu, Maria A Sartori, et al.
Nature Communications
|
October 27, 2023
N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity
Sylvia Varland, Rui Duarte Silva, Ine Kjosås, et al.
Cell Stem Cell
|
May 29, 2020
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma
Parvez Vora, Chitra Venugopal, Sabra Khalid Salim, et al.
Neuron
|
January 22, 2026
Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance
Nicholas Mikolajewicz, Kui Zhai, Anish Puri, et al.
Nature Metabolism
|
July 23, 2020
Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism
Michael Aregger, Keith A Lawson, Maximillian Billmann, et al.
Molecular & Cellular Proteomics : MCP
|
August 21, 2015
A High Through-put Platform for Recombinant Antibodies to Folded Proteins
Michael Hornsby, Marcin Paduch, Shane Miersch, et al.
Acta Neuropathologica
|
September 30, 2022
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers
Nazanin Tatari, Shahbaz Khan, Julie Livingstone, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 195) with videos related to
Sort By:
Page
of 20
Cell Reports
|
September 28, 2022
Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma
Maleeha A Qazi, Sabra K Salim, Kevin R Brown, et al.
Cell
|
July 10, 2004
Exploration of essential gene functions via titratable promoter alleles
Sanie Mnaimneh, Armaity P Davierwala, Jennifer Haynes, et al.
Nature
|
November 25, 2021
FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation
Yuqing Feng, Conglei Li, Jessica A Stewart, et al.
Molecular Cell
|
March 8, 2016
System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes
Wei Zhang, Kuen-Phon Wu, Maria A Sartori, et al.
Nature Communications
|
October 27, 2023
N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity
Sylvia Varland, Rui Duarte Silva, Ine Kjosås, et al.
Cell Stem Cell
|
May 29, 2020
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma
Parvez Vora, Chitra Venugopal, Sabra Khalid Salim, et al.
Neuron
|
January 22, 2026
Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance
Nicholas Mikolajewicz, Kui Zhai, Anish Puri, et al.
Nature Metabolism
|
July 23, 2020
Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism
Michael Aregger, Keith A Lawson, Maximillian Billmann, et al.
Molecular & Cellular Proteomics : MCP
|
August 21, 2015
A High Through-put Platform for Recombinant Antibodies to Folded Proteins
Michael Hornsby, Marcin Paduch, Shane Miersch, et al.
Acta Neuropathologica
|
September 30, 2022
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers
Nazanin Tatari, Shahbaz Khan, Julie Livingstone, et al.
Page
of 20